Molecular basis of two novel mutations found in type I methemoglobinemia
- 1 April 2011
- journal article
- case report
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 46 (4) , 277-281
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrumBrain, 2008
- A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate SpecificityScience, 2007
- Expression of a novel P275L variant of NADH:cytochrome b5 reductase gives functional insight into the conserved motif important for pyridine nucleotide bindingArchives of Biochemistry and Biophysics, 2006
- Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b5 reductase: An aid to determine recessive congenital methemoglobinemia status in an infantBlood Cells, Molecules, and Diseases, 2006
- Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH‐binding lobe of cytochrome b5 reductaseBritish Journal of Haematology, 2005
- Red Cell EnzymesHematology-American Society Hematology Education Program, 2005
- Compound heterozygosity of two missense mutations in the NADH‐cytochrome b5 reductase gene of a Polish patient with type I recessive congenital methaemoglobinaemiaEuropean Journal of Haematology, 2003
- Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (diaphorase 1) geneHuman Mutation, 2001
- Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membraneMolecular Aspects of Medicine, 1997
- NADH‐cytochrome b5 reductase and cytochrome b5 isoforms as models for the study of post‐translational targeting to the endoplasmic reticulumFEBS Letters, 1993